Evidence map›Paper›PMID 41537044›Full record

ArticleMalaysian orthopaedic journal2025

Exploring the Rare Occurrence of Giant Cell Tumour in Distal Tibia.

K Parakh-Naman, N Chauhan, R Mishra

Abstract read
In one paragraph

Article in Malaysian orthopaedic journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

K Parakh-NamanDepartment of Orthopaedics, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, India.
N ChauhanDepartment of Orthopaedics, Rama Medical College, Hospital and Research Centre, Hapur, India.
R MishraDepartment of Orthopaedics, Maulana Azad Medical College (MAMC), New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Giant cell tumours (GCT) of the distal tibia are uncommon, locally aggressive lesions that are frequently difficult to manage due to the anatomical and functional intricacies of the region. This case study seeks to elucidate the clinical presentation, surgical procedures, and results in three individuals with distal tibial giant cell tumours, highlighting management and reconstructive techniques in this uncommon location with higher risk of morbidity compared to other locations and to achieve pain free ambulation. Materials and methods: Three cases presenting with localised pain and swelling with painful weight-bearing in the distal tibia, were included in the study. Two patients had primary GCT whereas one had recurrence of the tumour after being managed elsewhere. All patients had biopsy and radiologically proven GCT with differing degrees of local aggressiveness. The management strategy involved wide-margin tumour resection followed by reconstruction techniques including contralateral fibular strut grafting and ankle arthrodesis with cementation and bone graft to restore structural integrity and functionality. Results: All three patients underwent successful tumour resection and reconstruction without major intra-operative complications. Radiological assessments confirmed adequate union of grafts and no signs of recurrence during follow-up. Conclusion: This series highlights the efficacy of various modalities for the treatment of GCT of distal tibia. While these methods demonstrate promising results in terms of stability and patient satisfaction, vigilance for recurrence and long-term complications remains critical.

Indexed as

aggressive lesionankle arthrodesisdistal tibiagiant cell tumourtumour resection

Identifiers

PMID41537044
PMCPMC12798111

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.